查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942756

2026年全球药物与基因递送设备市场报告

Drug And Gene Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物和基因递送装置的市场规模经历了显着增长，预计将从2025年的6.7亿美元增长到2026年的7.3亿美元，复合年增长率为8.9%。过去几年的成长可归因于先进递送装置的供不应求、对传统给药途径的依赖、早期基因疗法的开发、生物製药产品线的扩展以及对研究合作投入的增加。

预计未来几年，药物和基因递送装置市场将保持强劲成长，到2030年市场规模将达到10.1亿美元，复合年增长率（CAGR）为8.6%。预测期内的成长要素包括病毒和非病毒载体技术的进步、个人化医疗和基因治疗应用范围的扩大、创新递送系统监管核准的增加、奈米药物和脂质奈米颗粒（LNP）的日益普及，以及数位监测和智慧递送平台的整合。预测期内的主要趋势包括标靶药物和基因治疗的增长、基于奈米颗粒的递送系统应用的增加、病毒载体在基因治疗中的应用日益广泛、注射和非侵入性递送方法的扩展，以及对个性化医疗和缓释技术的关注。

基因疗法的日益普及预计将推动药物和基因递送装置市场的未来成长。基因疗法是一种透过修改患者细胞中的遗传物质来治疗或预防疾病的方法，因其有望解决遗传性和慢性疾病的根本原因而备受关注。基因疗法的广泛应用正在推动对先进递送系统的需求，这些系统能够实现治疗基因的精准标靶化和可控释放。药物和基因递送装置在提高治疗效果和安全性方面发挥着至关重要的作用。例如，根据美国非营利组织美国基因与细胞治疗学会（ASCG​​TC）的数据显示，截至2025年1月，2024年第四季的基因治疗计画预註册数量较第三季度增加了83%。因此，基因疗法的日益普及正在推动整个药物和基因递送装置市场的成长。

为了提升市场竞争力，製药和基因递送设备市场的主要企业正致力于开发先进解决方案，例如基于人工智慧（AI）的技术。人工智慧技术在药物传递领域的应用旨在透过应用先进的演算法和数据驱动模型，提高递送的准确性、效率和治疗效果。例如，2023年12月，总部位于美国的聚合物奈米颗粒开发商Emboya宣布推出一项创新的基因治疗递送平台，将生物聚合物奈米颗粒与人工智慧结合。该平台旨在解决现有基因递送方法面临的挑战，例如病毒载体和脂质奈米颗粒相关的安全问题、有效载荷能力有限以及组织标靶化不足等。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球药物及基因递送设备市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 标靶药物和基因治疗的发展
    • 奈米颗粒递送系统的应用日益广泛
    • 基因治疗中病毒载体的应用日益广泛
    • 拓展注射式和非侵入性给药方式
    • 专注于个人化医疗和缓释技术

第五章 终端用户产业市场分析

  • 製药公司
  • 生技公司
  • 医院和诊所
  • 研究所
  • 合约研究与製造组织（CRAMOS）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球药物和基因递送设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球药物和基因递送设备市场规模、对比及成长率分析
  • 全球药物和基因递送设备市场表现：规模和成长，2020-2025年
  • 全球药物和基因递送设备市场预测：规模和成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 向量
  • 病毒性和非病毒性
  • 透过方法
  • 原位，离体
  • 透过行政途径
  • 口服、吸入、经皮、注射、眼用、鼻用、局部用药
  • 按类型细分：病毒
  • 腺病毒载体、慢病毒载体、腺结合病毒（AAV）载体、单纯疱疹病毒（HSV）载体、逆转录病毒载体、桿状病毒载体、痘苗病毒载体、仙台病毒载体
  • 按类型细分：非病毒性
  • 脂质奈米颗粒（LNP）、聚合物奈米颗粒、脂质体、树状聚合物、裸露DNA/RNA递送、基于电穿孔的递送系统、基于奈米颗粒的递送系统、高分子奈米微胞和水凝胶

第十章 区域与国家分析

  • 全球药物与基因传递设备市场：区域分析、预测与成长，2020-2025年、2025-2030年预测、2035年预测
  • 全球药物和基因递送设备市场：按国家/地区划分，实际值和预测值，2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 药物和基因递送设备市场：竞争格局和市场份额，2024 年
  • 药物与基因递送设备市场：公司估值矩阵
  • 药物和基因递送设备市场：公司概况
    • Medtronic plc
    • Moderna Inc.
    • Halozyme Therapeutics Inc.
    • Uniqure NV
    • Intellia Therapeutics Inc.

第37章：其他领先和创新企业

  • Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics SA, CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药物和基因递送设备市场：提供新机会的国家
  • 2030年药物与基因传递设备市场：充满新机会的细分市场
  • 2030年药物与基因递送设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MDGDD01_G26Q1

Drug and gene delivery devices are technologies designed to transport medications or genetic material into the body for targeted therapy. They enable precise delivery to specific tissues or cells, reducing side effects and improving treatment effectiveness.

The key vector categories of drug and gene delivery devices include viral and non-viral vectors. Viral gene delivery uses genetically modified viruses to transport therapeutic genes into target cells. The delivery methods include in situ and ex vivo techniques, and the routes of administration include oral, inhalation, transdermal, injectable, ocular, nasal, and topical routes.

Tariffs are impacting the drug and gene delivery devices market by increasing the cost of imported materials, components, and specialized manufacturing equipment for viral and non-viral vector production. Segments such as lipid nanoparticles, polymeric nanoparticles, and viral vectors are most impacted, particularly in regions like North America and Asia-Pacific. While tariffs have raised production costs and slowed supply chains, they have also encouraged local manufacturing, investment in domestic capabilities, and innovation in alternative materials and delivery technologies.

The drug and gene delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug and gene delivery devices market statistics, including drug and gene delivery devices industry global market size, regional shares, competitors with a drug and gene delivery devices market share, detailed drug and gene delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug and gene delivery devices industry. This drug and gene delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug and gene delivery devices market size has grown strongly in recent years. It will grow from $0.67 billion in 2025 to $0.73 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to limited availability of advanced delivery devices, reliance on conventional administration routes, early-stage gene therapy development, growing biologics pipeline, increasing investment in research collaborations.

The drug and gene delivery devices market size is expected to see strong growth in the next few years. It will grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to technological advancements in viral and non-viral vectors, expansion of personalized medicine and gene therapy applications, increasing regulatory approvals for innovative delivery systems, rising adoption of nanomedicine and LNPs, integration of digital monitoring and smart delivery platforms. Major trends in the forecast period include growth of targeted drug and gene therapies, rising adoption of nanoparticle-based delivery systems, increasing use of viral vectors for gene therapy, expansion of injectable and non-invasive delivery methods, focus on personalized medicine and controlled release technologies.

The increasing adoption of gene therapy is anticipated to support the expansion of the drug and gene delivery devices market going forward. Gene therapy involves modifying genetic material within a patient's cells to treat or prevent disease and is gaining attention due to its potential to address genetic and chronic conditions at their underlying causes. The growing adoption of gene therapy has increased demand for advanced delivery systems capable of precise targeting and controlled release of therapeutic genes. Drug and gene delivery devices play a critical role in enhancing treatment effectiveness and safety. For example, in January 2025, according to the American Society of Gene & Cell Therapy, a US-based non-profit organization, the number of pre-registration gene therapy programs in Q4 2024 increased by 83% compared to Q3 2024. As a result, the expanding adoption of gene therapy is reinforcing growth across the drug and gene delivery devices market.

Leading companies operating in the drug and gene delivery devices market are focusing on developing advanced solutions, such as artificial intelligence (AI)-enabled technologies, to enhance market competitiveness. AI technology in drug delivery involves the application of advanced algorithms and data-driven models to improve delivery precision, efficiency, and therapeutic effectiveness. For example, in December 2023, Envoya Inc., a US-based developer of polymer-based nanoparticles, launched an innovative gene therapy delivery platform that combines biopolymer nanoparticles with AI. This platform is designed to address limitations of existing gene delivery methods, including safety concerns, restricted payload capacity, and limited tissue targeting associated with viral vectors and lipid nanoparticles.

In January 2025, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, acquired Poseida Therapeutics Inc. for $1.5 billion. Through this acquisition, Roche aims to strengthen its oncology pipeline and expand its capabilities in allogeneic CAR-T cell therapies targeting blood cancers, solid tumors, and autoimmune diseases. Poseida Therapeutics Inc. is a US-based company specializing in complex immune cell therapies, including genetically modified CAR-T therapies for cancer and autoimmune disorders.

Major companies operating in the drug and gene delivery devices market are Medtronic plc, Moderna Inc., Halozyme Therapeutics Inc., Uniqure NV, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation, ICU Medical, Stevanato Group, Gerresheimer AG, Ypsomed, SHL Medical

North America was the largest region in the drug and gene delivery devices market in 2025. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug and gene delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug and gene delivery devices market consists of sales of microspheres and microneedles, electroporation devices, bio adhesive systems, and gene therapy vectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug And Gene Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug and gene delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug and gene delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug and gene delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Vector: Viral; Non-viral
  • 2) By Method: In Situ; Ex Vivo
  • 3) By Route Of Administration: Oral; Inhalation; Transdermal; Injectable; Ocular; Nasal; Topical
  • Subsegments:
  • 1) By Viral: Adenovirus Vectors; Lentivirus Vectors; Adeno-Associated Virus (AAV) Vectors; Herpes Simplex Virus (HSV) Vectors; Retrovirus Vectors; Baculovirus Vectors; Vaccinia Virus Vectors; Sendai Virus Vectors
  • 2) By Non-Viral: Lipid Nanoparticles (LNP); Polymeric Nanoparticles; Liposomes; Dendrimers; Naked DNA/RNA Delivery; Electroporation-Based Delivery Systems; Nanoparticle-Based Delivery Systems; Polymer Micelles And Hydrogels.
  • Companies Mentioned: Medtronic plc; Moderna Inc.; Halozyme Therapeutics Inc.; Uniqure NV; Intellia Therapeutics Inc.; Voyager Therapeutics Inc.; sfm medical devices GmbH; Inovio Pharmaceuticals Inc.; GenSight Biologics S.A.; CRISPR Therapeutics; Pfizer Inc.; Novartis AG; Becton Dickinson and Company; Shanghai Sunway Biotech Co Ltd; Epeius Biotechnologies Corporation; SiBiono GeneTech Co Ltd; F Hoffmann-La Roche Ltd; Baxter International; B Braun Melsungen; Terumo Corporation; ICU Medical; Stevanato Group; Gerresheimer AG; Ypsomed; SHL Medical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug And Gene Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug And Gene Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug And Gene Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug And Gene Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Growth Of Targeted Drug And Gene Therapies
    • 4.2.2 Rising Adoption Of Nanoparticle-Based Delivery Systems
    • 4.2.3 Increasing Use Of Viral Vectors For Gene Therapy
    • 4.2.4 Expansion Of Injectable And Non-Invasive Delivery Methods
    • 4.2.5 Focus On Personalized Medicine And Controlled Release Technologies

5. Drug And Gene Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biotechnology Companies
  • 5.3 Hospitals And Clinics
  • 5.4 Research Laboratories
  • 5.5 Contract Research And Manufacturing Organizations (Cramos)

6. Drug And Gene Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug And Gene Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug And Gene Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug And Gene Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug And Gene Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug And Gene Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug And Gene Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug And Gene Delivery Devices Market Segmentation

  • 9.1. Global Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Viral, Non-viral
  • 9.2. Global Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Situ, Ex Vivo
  • 9.3. Global Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
  • 9.4. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
  • 9.5. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Non-Viral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels

10. Drug And Gene Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Drug And Gene Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug And Gene Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug And Gene Delivery Devices Market

  • 11.1. Asia-Pacific Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug And Gene Delivery Devices Market

  • 12.1. China Drug And Gene Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug And Gene Delivery Devices Market

  • 13.1. India Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug And Gene Delivery Devices Market

  • 14.1. Japan Drug And Gene Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug And Gene Delivery Devices Market

  • 15.1. Australia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug And Gene Delivery Devices Market

  • 16.1. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug And Gene Delivery Devices Market

  • 17.1. South Korea Drug And Gene Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug And Gene Delivery Devices Market

  • 18.1. Taiwan Drug And Gene Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug And Gene Delivery Devices Market

  • 19.1. South East Asia Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug And Gene Delivery Devices Market

  • 20.1. Western Europe Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug And Gene Delivery Devices Market

  • 21.1. UK Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug And Gene Delivery Devices Market

  • 22.1. Germany Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug And Gene Delivery Devices Market

  • 23.1. France Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug And Gene Delivery Devices Market

  • 24.1. Italy Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug And Gene Delivery Devices Market

  • 25.1. Spain Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug And Gene Delivery Devices Market

  • 26.1. Eastern Europe Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug And Gene Delivery Devices Market

  • 27.1. Russia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug And Gene Delivery Devices Market

  • 28.1. North America Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug And Gene Delivery Devices Market

  • 29.1. USA Drug And Gene Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug And Gene Delivery Devices Market

  • 30.1. Canada Drug And Gene Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug And Gene Delivery Devices Market

  • 31.1. South America Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug And Gene Delivery Devices Market

  • 32.1. Brazil Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug And Gene Delivery Devices Market

  • 33.1. Middle East Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug And Gene Delivery Devices Market

  • 34.1. Africa Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug And Gene Delivery Devices Market Regulatory and Investment Landscape

36. Drug And Gene Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Drug And Gene Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug And Gene Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug And Gene Delivery Devices Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Halozyme Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Uniqure NV Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Intellia Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Drug And Gene Delivery Devices Market Other Major And Innovative Companies

  • Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation

38. Global Drug And Gene Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug And Gene Delivery Devices Market

40. Drug And Gene Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Drug And Gene Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug And Gene Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug And Gene Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer